Our results provide a global mapping of human valvular apolipoproteins, open new avenues to study the interplay between apolipoproteins and CAVD, and implicate apoC-III as an active and modifiable contributor to human valvular calcification. Here, APOC3 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.